The Oncosearch | Oncotarget

Novel strategies to target the ubiquitin proteasome system in multiple myeloma Review

Susanne Lub, Ken Maes, Eline Menu, Elke De Bruyne, Karin Vanderkerken, Els Van Valckenborgh

Published Dec 18, 2015 · Vol. 7, No. 6 · pp. 6521-6537

Recurrent AKT mutations in human cancers: functional consequences and effects on drug sensitivity Research Paper

Kyung H. Yi, Josh Lauring

Published Dec 17, 2015 · Vol. 7, No. 4 · pp. 4241-4251

Sorafenib treatment during partial hepatectomy reduces tumorgenesis in an inflammation-associated liver cancer model Research Paper

Tamar Zahavi, Tali Lanton, Mali Salmon Divon, Asher Salmon, Tamar Peretz, Eithan Galun, Jonathan H. Axelrod, Amir Sonnenblick

Published Dec 17, 2015 · Vol. 7, No. 4 · pp. 4860-4870

Identification of a new class of WNT1 inhibitor: Cancer cells migration, G-quadruplex stabilization and target validation Research Paper

Lien-Cheng Chang, Tsung-Chih Chen, Shiag-Jiun Chen, Chun-Liang Chen, Chia-Chung Lee, Shih-Hsiung Wu, Yun Yen, Hsu-Shan Huang, Jing-Jer Lin

Published Dec 15, 2015 · Vol. 7, No. 42 · pp. 67986-68001

Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b Research Paper

Elisabetta Vergani, Lorenza Di Guardo, Matteo Dugo, Sara Rigoletto, Gabrina Tragni, Roberta Ruggeri, Federica Perrone, Elena Tamborini, Annunziata Gloghini, Flavio Arienti, Barbara Vergani, Paola Deho, Loris De Cecco, Viviana Vallacchi, Paola Frati, Eriomina Shahaj, Antonello Villa, Mario Santinami, Filippo De Braud, Licia Rivoltini, Monica Rodolfo

Published Dec 14, 2015 · Vol. 7, No. 4 · pp. 4428-4441

Primary cross-resistance to BRAFV600E-, MEK1/2- and PI3K/mTOR-specific inhibitors in BRAF-mutant melanoma cells counteracted by dual pathway blockade Research Paper

Ilaria Penna, Alessandra Molla, Giulia Grazia, Loredana Cleris, Gabriella Nicolini, Federica Perrone, Benedetta Picciani, Michele Del Vecchio, Filippo de Braud, Roberta Mortarini, Andrea Anichini

Published Dec 14, 2015 · Vol. 7, No. 4 · pp. 3947-3965

Identification of the BRAF V600E mutation in gastroenteropancreatic neuroendocrine tumors Research Paper

Charny Park, Sang Yun Ha, Seung Tae Kim, Hee Cheol Kim, Jin Seok Heo, Young Suk Park, Gregory Lauwers, Jeeyun Lee, Kyoung-Mee Kim

Published Dec 14, 2015 · Vol. 7, No. 4 · pp. 4024-4035

MTDH is an oncogene in multiple myeloma, which is suppressed by Bortezomib treatment Research Paper

Chunyan Gu, Lang Feng, Hailin Peng, Hongbao Yang, Zhenqing Feng, Ye Yang

Published Dec 14, 2015 · Vol. 7, No. 4 · pp. 4559-4569

A chemotherapy response classifier based on support vector machines for high-grade serous ovarian carcinoma Research Paper

Chao-Yang Sun, Tie-Fen Su, Na Li, Bo Zhou, En-Song Guo, Zong-Yuan Yang, Jing Liao, Dong Ding, Qin Xu, Hao Lu, Li Meng, Shi-Xuan Wang, Jian-Feng Zhou, Hui Xing, Dan-Hui Weng, Ding Ma, Gang Chen

Published Dec 12, 2015 · Vol. 7, No. 3 · pp. 3245-3254

Metformin increases antitumor activity of MEK inhibitors through GLI1 downregulation in LKB1 positive human NSCLC cancer cells Research Paper

Carminia Maria Della Corte, Vincenza Ciaramella, Concetta Di Mauro, Maria Domenica Castellone, Federica Papaccio, Morena Fasano, Ferdinando Carlo Sasso, Erika Martinelli, Teresa Troiani, Ferdinando De Vita, Michele Orditura, Roberto Bianco, Fortunato Ciardiello, Floriana Morgillo

Published Dec 11, 2015 · Vol. 7, No. 4 · pp. 4265-4278

Mps1 is SUMO-modified during the cell cycle Research Paper

Agnese Restuccia, Feikun Yang, Changyan Chen, Lou Lu, Wei Dai

Published Dec 10, 2015 · Vol. 7, No. 3 · pp. 3158-3170

Combinatorial drug screening and molecular profiling reveal diverse mechanisms of intrinsic and adaptive resistance to BRAF inhibition in V600E BRAF mutant melanomas Research Paper

Devin G. Roller, Brian Capaldo, Stefan Bekiranov, Aaron J. Mackey, Mark R. Conaway, Emanuel F. Petricoin, Daniel Gioeli, Michael J. Weber

Published Dec 10, 2015 · Vol. 7, No. 3 · pp. 2734-2753

miR-30a inhibits endothelin A receptor and chemoresistance in ovarian carcinoma Research Paper

Rosanna Sestito, Roberta Cianfrocca, Laura RosanÃ², Piera Tocci, Elisa Semprucci, Valeriana Di Castro, Valentina Caprara, Gabriella Ferrandina, Andrea Sacconi, Giovanni Blandino, Anna Bagnato

Published Dec 10, 2015 · Vol. 7, No. 4 · pp. 4009-4023

Possible prediction of the response of esophageal squamous cell carcinoma to neoadjuvant chemotherapy based on gene expression profiling Research Paper

Lu-Yan Shen, Hui Wang, Bin Dong, Wan-Pu Yan, Yao Lin, Qi Shi, Ke-Neng Chen

Published Dec 10, 2015 · Vol. 7, No. 4 · pp. 4531-4541

Gamabufotalin, a major derivative of bufadienolide, inhibits VEGF-induced angiogenesis by suppressing VEGFR-2 signaling pathway Research Paper

Ning Tang, Lei Shi, Zhenlong Yu, Peipei Dong, Chao Wang, Xiaokui Huo, Baojing Zhang, Shanshan Huang, Sa Deng, Kexin Liu, Tonghui Ma, Xiaobo Wang, Lijun Wu, Xiaochi Ma

Published Dec 9, 2015 · Vol. 7, No. 3 · pp. 3533-3547

Auranofin-mediated inhibition of PI3K/AKT/mTOR axis and anticancer activity in non-small cell lung cancer cells Research Paper

Hongyu Li, Jing Hu, Shuhong Wu, Li Wang, Xiaobo Cao, Xiaoshan Zhang, Bingbing Dai, Mengru Cao, Ruping Shao, Ran Zhang, Mourad Majidi, Lin Ji, John V. Heymach, Michael Wang, Shiyang Pan, John Minna, Reza J. Mehran, Stephen G. Swisher, Jack A. Roth, Bingliang Fang

Published Dec 9, 2015 · Vol. 7, No. 3 · pp. 3548-3558

Epigenetic effects of RRx-001: a possible unifying mechanism of anticancer activity Priority Research Paper

Hongjuan Zhao, Shoucheng Ning, Jan Scicinski, Bryan Oronsky, Susan J. Knox, Donna M. Peehl

Published Dec 9, 2015 · Vol. 6, No. 41 · pp. 43172-43181

Metronomic topotecan impedes tumor growth of MYCN-amplified neuroblastoma cells in vitro and in vivo by therapy induced senescence Research Paper

Sabine Taschner-Mandl, Magdalena Schwarz, Johanna Blaha, Maximilian Kauer, Florian Kromp, Nelli Frank, Fikret Rifatbegovic, Tamara Weiss, Ruth Ladenstein, Martin Hohenegger, Inge M. Ambros, Peter F. Ambros

Published Dec 9, 2015 · Vol. 7, No. 3 · pp. 3571-3586

90 Y-ibritumomab tiuxetan: a nearly forgotten opportunity Review

Patrizia Mondello, Salvatore Cuzzocrea, Michele Navarra, Michael Mian

Published Dec 9, 2015 · Vol. 7, No. 7 · pp. 7597-7609

The Toll-like receptor 5 agonist entolimod suppresses hepatic metastases in a murine model of ocular melanoma via an NK cell-dependent mechanism Research Paper

Hua Yang, Craig M. Brackett, Vanessa Marie Morales-Tirado, Zezhong Li, Qing Zhang, Matthew W. Wilson, Camille Benjamin, Wayne Harris, Edmund K. Waller, Andrei V. Gudkov, Lyudmila G. Burdelya, Hans E. Grossniklaus

Published Dec 8, 2015 · Vol. 7, No. 3 · pp. 2936-2950

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Novel strategies to target the ubiquitin proteasome system in multiple myeloma Review

Recurrent AKT mutations in human cancers: functional consequences and effects on drug sensitivity Research Paper

Sorafenib treatment during partial hepatectomy reduces tumorgenesis in an inflammation-associated liver cancer model Research Paper

Identification of a new class of WNT1 inhibitor: Cancer cells migration, G-quadruplex stabilization and target validation Research Paper

Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b Research Paper

Primary cross-resistance to BRAFV600E-, MEK1/2- and PI3K/mTOR-specific inhibitors in BRAF-mutant melanoma cells counteracted by dual pathway blockade Research Paper

Identification of the BRAF V600E mutation in gastroenteropancreatic neuroendocrine tumors Research Paper

MTDH is an oncogene in multiple myeloma, which is suppressed by Bortezomib treatment Research Paper

A chemotherapy response classifier based on support vector machines for high-grade serous ovarian carcinoma Research Paper

Metformin increases antitumor activity of MEK inhibitors through GLI1 downregulation in LKB1 positive human NSCLC cancer cells Research Paper

Mps1 is SUMO-modified during the cell cycle Research Paper

Combinatorial drug screening and molecular profiling reveal diverse mechanisms of intrinsic and adaptive resistance to BRAF inhibition in V600E BRAF mutant melanomas Research Paper

miR-30a inhibits endothelin A receptor and chemoresistance in ovarian carcinoma Research Paper

Possible prediction of the response of esophageal squamous cell carcinoma to neoadjuvant chemotherapy based on gene expression profiling Research Paper

Gamabufotalin, a major derivative of bufadienolide, inhibits VEGF-induced angiogenesis by suppressing VEGFR-2 signaling pathway Research Paper

Auranofin-mediated inhibition of PI3K/AKT/mTOR axis and anticancer activity in non-small cell lung cancer cells Research Paper

Epigenetic effects of RRx-001: a possible unifying mechanism of anticancer activity Priority Research Paper

Metronomic topotecan impedes tumor growth of MYCN-amplified neuroblastoma cells in vitro and in vivo by therapy induced senescence Research Paper

90 Y-ibritumomab tiuxetan: a nearly forgotten opportunity Review

The Toll-like receptor 5 agonist entolimod suppresses hepatic metastases in a murine model of ocular melanoma via an NK cell-dependent mechanism Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Novel strategies to target the ubiquitin proteasome system in multiple myeloma Review

Recurrent AKT mutations in human cancers: functional consequences and effects on drug sensitivity Research Paper

Sorafenib treatment during partial hepatectomy reduces tumorgenesis in an inflammation-associated liver cancer model Research Paper

Identification of a new class of WNT1 inhibitor: Cancer cells migration, G-quadruplex stabilization and target validation Research Paper

Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b Research Paper

Primary cross-resistance to BRAFV600E-, MEK1/2- and PI3K/mTOR-specific inhibitors in BRAF-mutant melanoma cells counteracted by dual pathway blockade Research Paper

Identification of the BRAF V600E mutation in gastroenteropancreatic neuroendocrine tumors Research Paper

MTDH is an oncogene in multiple myeloma, which is suppressed by Bortezomib treatment Research Paper

A chemotherapy response classifier based on support vector machines for high-grade serous ovarian carcinoma Research Paper

Metformin increases antitumor activity of MEK inhibitors through GLI1 downregulation in LKB1 positive human NSCLC cancer cells Research Paper

Mps1 is SUMO-modified during the cell cycle Research Paper

Combinatorial drug screening and molecular profiling reveal diverse mechanisms of intrinsic and adaptive resistance to BRAF inhibition in V600E BRAF mutant melanomas Research Paper

miR-30a inhibits endothelin A receptor and chemoresistance in ovarian carcinoma Research Paper

Possible prediction of the response of esophageal squamous cell carcinoma to neoadjuvant chemotherapy based on gene expression profiling Research Paper

Gamabufotalin, a major derivative of bufadienolide, inhibits VEGF-induced angiogenesis by suppressing VEGFR-2 signaling pathway Research Paper

Auranofin-mediated inhibition of PI3K/AKT/mTOR axis and anticancer activity in non-small cell lung cancer cells Research Paper

Epigenetic effects of RRx-001: a possible unifying mechanism of anticancer activity Priority Research Paper

Metronomic topotecan impedes tumor growth of MYCN-amplified neuroblastoma cells in vitro and in vivo by therapy induced senescence Research Paper

90 Y-ibritumomab tiuxetan: a nearly forgotten opportunity Review

The Toll-like receptor 5 agonist entolimod suppresses hepatic metastases in a murine model of ocular melanoma via an NK cell-dependent mechanism Research Paper